Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Champion Pacific Indonesia Tbk. (IGAR) Price & Performance

Cipta Sarana Medika Tbk.Trade
Champion Pacific Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Champion Pacific Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp414 (market cap 384.1B, 16.2K 24h volume). The key difference: Champion Pacific Indonesia Tbk. is far larger — about 2.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 16.2K). Which is the better fit depends on your goals.

DKHHIGAR
Market Cap
158.12B384.1B
Volume
8.21M16.2K
Lot
82.15K162
Turnover
515.2M6.65M
Average Price
62.72410.64
Value
515.2M6.65M
Indicative Equilibrium Price
63414
Indicative Equilibrium Volume
1.33K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
IGAR
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Champion Pacific Indonesia Tbk.

PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.

Read more on IGAR